VirTra Shines with Record-Breaking Revenue, Beam Global Beats Expectations, Eloxx Pharmaceuticals Misses Estimates, Ducommun Launches Public Offering
- May 15th, 2023
- 546 views
VirTra, Inc. (Nasdaq: VTSI) achieved remarkable double-digit millions in quarterly revenue for the first time, surpassing expectations with Q1 2023 earnings per share (EPS) of $0.27 compared to the consensus estimate of $0.04.
In after-hours trading, $VTSI is currently valued at $6.99, experiencing a notable increase of $1.07 (+18.07%).
Beam Global (Nasdaq: BEEM) reported a loss of $0.38 per share for the first quarter 2023, performing better than the consensus estimate of a loss of $0.42 per share.
$BEEM is trading at $11.69 in after-hours, reflecting a significant gain of $1.66 (+16.55%).
Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) reported a loss of $2.88 per share for Q1 2023, worse than the consensus estimate of a loss of $2.55 per share.
In after-hours trading, $ELOX is currently valued at $8.23, experiencing a decline of $2.67 (-24.50%).
Ducommun Incorporated (NYSE: DCO) announced the launch of an underwritten public offering of 2,000,000 shares of its common stock.
Following this announcement, $DCO is trading at $43.75 in after-hours, indicating a decrease of $4.67 (-9.64%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login